INTRODUCTION
Seldom has a disease evoked more interest and dreadful fear in the common man like it has for cancer. Breast cancer amongst all cancers, continue to evoke such responses and even more research, especially since the treatment involves surgery which leaves physical and emotional scars in its victims.
Breast carcinoma is the commonest cancer in women. It is the leading cause of death in women, with more than one million cases occuring worldwide annually. Breast cancer represents an important public health issue, having a high occurence worldwide, with an obvious increasing tendency.
The Edwin Smith Surgical Papyrus is having the first reference to breast cancer. This surgical text, described in hieratic script, is the incomplete copy of an original record that dates back to the pyramid age of Egypt (3000-2500BC) . 
AIMS AND OBJECTIVES
• To study the stromal expression of CD10 in breast carcinoma
• To study relationship with certain prognostic factors like,
Age, 2. Nottingham's grade and 3. ER, PR, HER2neu
• To study the role of stroma in the pathogenesis of breast cancer
• To study the role of CD10 in triple negative cases
MATERIALS AND METHODS
A total of 75 cases of breast cancer were included in the study. Representative sections were taken and hematoxylin and eosin staining was done.
Immunohistochemistry was performed with ER, PR, Her2neu and CD10. Stromal expression of CD10 (>10% stromal positivity was considered positive) in invasive breast carcinoma was noted and was statistically analyzed with different known prognostic markers of breast carcinoma.
RESULTS
Stromal expression of CD10 was found to be significantly associated with increasing tumor grade (P = <0.0001), ER negativity (P = <0.0001), PR negativity (P = <0.0001), Her2neu positivity (P = <0.0001) and with triple negative cases. No correlation was found between CD10 overexpression and age of the patient. 
CONCLUSION
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